Claraphi Advisory Network’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AWA
Claraphi Advisory Network's PFE Position: Q4 2022 in Review
Claraphi Advisory Network increased its Pfizer (PFE) stake by 39% in Q4 2022, buying an estimated $197K and bringing the position to 14,736 shares worth $755K. The position accounts for 0.3% of the portfolio, ranked #94.
Claraphi Advisory Network first reported a position in PFE in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.24M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Claraphi Advisory Network held 14,736 shares of Pfizer worth $755K as of Q4 2022.
- Claraphi Advisory Network bought 4,105 Pfizer shares in Q4 2022, an estimated $197K.
- Pfizer made up 0.3% of Claraphi Advisory Network's portfolio in Q4 2022, its #94 holding.
- Claraphi Advisory Network first reported a position in Pfizer in Q4 2017 and has held it in 21 quarters since.
- Claraphi Advisory Network's Pfizer position peaked at $1.24M in Q4 2021.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.